Veozah vs. HRT: does the non-hormonal option work as well as estradiol?

Does Veozah work as well as HRT for hot flashes?

Hormone therapy remains the most effective treatment for hot flashes, says The Menopause Society in its 2022 position statement. That holds across pills, patches, gels and doses of estrogen. A large Cochrane review pooled 24 randomized trials of estrogen, alone or with a progestin. Women on hormones had about 75% fewer hot flashes than women on placebo. Women on placebo improved too, with about 58% fewer hot flashes than at the start.

Veozah's trial record is solid, just smaller. In the SKYLIGHT 1 trial, published in The Lancet, women started with about 10 to 12 moderate to severe hot flashes a day. At week 12, women on the 45 mg dose had about 6.4 fewer hot flashes a day. Women on placebo had about 3.9 fewer. That gap of about two and a half hot flashes a day was enough for FDA approval. Women who stayed on Veozah kept the benefit through a full year.

No trial has tested Veozah and estradiol head to head in the same women. So any comparison sets two separate placebo trials side by side. Read that way, the pattern is steady: hormone therapy cuts hot flashes more, and more reliably. That doesn't make Veozah weak. The fair label is a real non-hormonal option, not an equal swap.

How Veozah and HRT work, and why it matters

The two drugs treat the same symptom in opposite ways. Veozah, whose generic name is fezolinetant, blocks NK3 receptors. These are docking spots in the hypothalamus, the brain's temperature control center. As estrogen drops, a signal there goes into overdrive and sets off the sudden heat of a hot flash. Veozah quiets that signal. It contains no estrogen, no progesterone, and no hormone of any kind. For the full walk-through and how to take the tablet, see how Veozah works.

Hormone therapy takes the direct route. It replaces the estrogen your ovaries have stopped making. If you still have a uterus, you also take progesterone to protect its lining. Because HRT treats the hormone drop itself, it reaches further. Bones, vaginal and bladder tissue, sleep, and mood can all respond to estrogen. Veozah is a precision tool for one symptom. HRT is a broader treatment, with broader risks to match. For how this works before your periods stop, see hormone therapy in perimenopause.

Is Veozah safer than HRT? What the boxed liver warning means

Not automatically. On December 16, 2024, the FDA added a boxed warning to Veozah for rare but serious liver injury. A boxed warning is the FDA's strongest safety label. It followed the report of a woman who fell ill about 40 days after starting the drug. She had fatigue, nausea, itching, yellow skin, pale stools and dark urine. Her liver tests returned to normal after she stopped Veozah.

The warning changed what happens before and during treatment. Your prescriber tracks your liver with simple blood tests:

• Before you start: a liver blood test. Veozah isn't started if liver enzymes or bilirubin are already twice the normal upper limit or more.
• First three months: a repeat test every month.
• Months 6 and 9: one more test each time.

Veozah is ruled out for three groups. Women with known cirrhosis, meaning scarring of the liver, can't take it. Women with severe kidney disease or kidney failure can't either. It also can't be combined with CYP1A2 inhibitors, drugs that slow how the body clears Veozah. One example is fluvoxamine, an antidepressant that raised Veozah exposure by more than 800% in testing.

For a woman with normal liver tests and no clashing medicines, the risk stays low. Still, know the warning signs. Stop the drug and call your clinician if you notice fatigue, yellow skin or eyes, dark urine, or unusual belly pain.

HRT's warnings have moved the other way. On February 12, 2026, the FDA approved new labels for the first group of hormone products. They drop heart disease, breast cancer and dementia from the boxed warning. For estrogen taken alone, the boxed warning about cancer of the uterine lining stays.

What are HRT's risks, and who shouldn't take it?

HRT's risks are better studied and generally low. But some health histories rule it out. Estrogen product labels and doctors agree on the main ones:

• Breast cancer, now or in the past
• Vaginal bleeding that hasn't been explained
• A past blood clot in a leg or lung, or a known clotting disorder
• A past stroke or heart attack
• Liver disease

For women without those histories, The Menopause Society calls the added risks rare. In its 2022 statement, rare means fewer than 1 extra case per 1,000 women a year. These rare risks include blood clots. With estrogen plus progestin, they also include stroke and breast cancer. In women under 60, estrogen taken alone was not linked to more breast cancer.

How you take estrogen matters. Pills pass through the liver first and raise clotting factors more. Transdermal forms, meaning patches, gels and sprays absorbed through the skin, appear to carry a lower risk of clots and stroke. That's why doctors favor them for women who already have some clotting risk. Timing matters too. Starting within about ten years of your last period, and before 60, gives the best balance of benefit and risk.

Side effects day to day: what to expect on each

Beyond the warnings, both drugs have common, milder side effects in the first weeks.

• Veozah: belly pain, diarrhea, trouble sleeping, back pain, and higher liver enzymes on blood tests. Hot flashes also appear on the label's list, which surprises many women.
• HRT: breast tenderness, bloating, headaches, and spotting or breakthrough bleeding, mostly in the first few months. Nausea is more common with estrogen pills.
• Both: side effects often ease within three to six months. One that hasn't budged by then is a reason to ask about a different dose or form.

For HRT's early side effects, what's normal, and what needs a same-day call, see HRT side effects.

Who is Veozah for, and who is HRT for?

Put how each drug works next to its safety record, and the picture gets clearer.

• Veozah may fit best if you had estrogen-sensitive breast cancer. It was mostly studied outside this group, so make the choice with your oncologist.
• Veozah may also fit if you have a history of blood clots, didn't tolerate HRT, or simply prefer no hormones. Normal liver tests are a must.
• HRT may fit best if you're within about ten years of your last period or under 60, with none of the conditions above. It gives the strongest relief.
• HRT also fits if you want its wider benefits. These include bone protection, relief of vaginal and bladder symptoms, and often better sleep. Veozah isn't approved for any of them.
• Neither is a clear fit with liver disease. HRT is ruled out with liver disease, and Veozah with cirrhosis. Raise any liver history early.

For the wider range of options, including SSRIs, gabapentin and other non-hormonal medicines, see menopause treatment options. For HRT dose ranges by form, see HRT dosage.

How much does Veozah cost vs. HRT in 2026?

The two sit at opposite ends of the price range, and insurance changes both. Here is the quick answer by situation.

• Cheapest overall: generic estradiol pills from your local pharmacy with a free discount coupon.
• Simplest online: a menopause clinic like Winona or Alloy, which ships FDA-approved estradiol to your door.
• With commercial insurance: Veozah's copay card can bring it down to about $30 a month. For HRT, Midi Health bills many PPO plans.

What Veozah costs

• Cash, no discount: about $780 a month at the pharmacy counter.
• With a free coupon: about $465–$545 a month through GoodRx or SingleCare. Walmart is usually lowest.
• With commercial insurance and the copay card: $0 the first month · About $30 a month after · Up to $4,000 of help a year · Not valid with Medicare, Medicaid or Tricare.

A copay card is a coupon from the drug maker that lowers what you pay at the pharmacy. Veozah's list price, what the maker charges wholesalers, is about $585 a month. Astellas says about 88% of commercially insured people had some Veozah coverage in December 2025. Many plans still require prior authorization, meaning your doctor must get the plan's approval first. Some also require step therapy, meaning you must try HRT or rule it out first. There's no generic fezolinetant yet, and its patents run to about 2034. Full detail is at Veozah's real 2026 cost.

What HRT costs

• Generic estradiol pills with a coupon: about $10–$15 a month.
• Generic estradiol patch with a coupon: about $35–$70 a month.
• Winona: from about $40 a month · Estradiol pills about $55 a month · Patch about $150 a month · No visit fee. Its patch, pills and progesterone capsules are FDA-approved.
• Alloy: estradiol patch about $100 a month · Progesterone from about $25 a month · One-time consult about $50.
• Midi Health: self-pay visits about $250 for the first, then $150 each. It bills many PPO plans, so you may pay only a copay. Medication is extra.

The full breakdown, with hidden fees, is at how much HRT costs and the cheapest ways to get HRT.

Over a year, the gap is wide. Veozah at the full cash price runs about $9,400. With a free coupon, it drops to about $5,600. With the copay card, a year costs about $330, counting the free first month. Generic estradiol and progesterone pills with a coupon can total about $275–$540 a year. Alloy's patch plus progesterone comes to about $1,525 in year one, consult included. With commercial insurance, the copay card or your plan's drug list often matters more than the sticker price.

Can you switch from Veozah to HRT, or use both together?

Switching is common. It's often driven by insurance as much as by symptoms. Many women start on HRT, find it doesn't suit them, and move to Veozah. That order matches how many insurers set up step therapy. The reverse happens too. A woman starts Veozah assuming hormones are off the table, then learns she's a fine HRT candidate.

Using both together is less settled. The two act on different pathways, so there's no obvious clash. But Veozah was studied on its own, not as an add-on to hormone therapy. There's little trial data on the pair. If one only partly helps, ask your prescriber whether adding the other makes sense for you.

So which one should you start with?

Your own health history does most of the sorting. A few honest questions settle it faster than any trial data.

• Any history of breast cancer, unexplained bleeding, stroke, or blood clots? That likely points to Veozah or another non-hormonal path, and to a specialist either way.
• Within about ten years of your last period, under 60, and none of those? HRT is generally the stronger starting point for hot flashes, per The Menopause Society.
• Only hot flashes and night sweats, with no need for bone, vaginal or sleep support? Veozah's narrow focus may be a fair trade for skipping hormones.
• Normal liver tests, healthy kidneys, and no CYP1A2 inhibitor like fluvoxamine? Those, not preference alone, are what clear you for Veozah.
• What does your insurance require? Some plans want a documented HRT trial before they cover Veozah. That paperwork sometimes decides the order.

Neither answer is permanent. A choice that doesn't fit at 47 can look different at 52. Switching is a normal part of this transition, not a sign the first choice was wrong.